Wondfo Biotech Co. Ltd, a Guangzhou, China-based manufacturer of rapid diagnostic medical devices, secured an investment license to open a unit in Kampala, Uganda Investment Authority (UIA) said in a Monday statement.
According to UIA, Wondfo is “one of the world’s biggest and fastest-growing manufacturers of medical diagnostic products and reagents” and the license was processed in 30 minutes. In Uganda, the company wants to “manufacture point of care products”, reads the statement.
UIA Director General, Robert Mukiza, said the authority is keen on attracting more investments in the pathogenic economy and intends to develop an industrial park solely for pathogenic industry manufacturers.
He also noted that they are expediting the process of acquiring investment licenses in order to speed up the setup of critical investment projects.
The Chinese firm was started in 1992 and it’s involved in research and development, manufacture and sales of rapid diagnostic reagents and related equipment.
It employs more than 1,100 employees in China.
After the outbreak of Covid-9, it developed multiple diagnostic products to efficiently detect the virus. Wondfo is the second company in the pathogenic industry that UIA has licensed in one month.
The other is Jena Herbals Uganda Ltd., which manufactures the well-received Covidex.